[CRVS] QoQ Quarter Result on 30-Jun-2018 [#Q2]

Stock
[CRVS] Corvus Pharmaceuticals, Inc.
Announcement Date
02-Aug-2018
Financial Year
2018
Quarter
30-Jun-2018 [#Q2]
Profit Trend
QoQ- 18.67%
YoY- 22.36%
Quarter Report
CRVS's Result
CRVS's Financial Summary
View:
Show?
Quarter Result
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -11,643 -10,509 -10,498 -11,631 -14,301 -11,929 -12,717 -5.71%
Tax 0 -180 0 0 0 -219 0 -
NP -11,643 -10,509 -10,498 -11,631 -14,301 -11,929 -12,717 -5.71%
Tax Rate - - - - - - - -
Total Cost 11,643 10,509 10,498 11,631 14,301 11,929 12,717 -5.71%
Ratio Analysis
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
EPS -0.40 -0.36 -0.36 -0.40 -0.63 -0.58 -0.62 -25.35%
EPS Diluted -0.40 -0.36 -0.36 -0.40 -0.63 -0.58 -0.62 -25.35%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.